These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23786919)

  • 1. Natural history of alpha mannosidosis a longitudinal study.
    Beck M; Olsen KJ; Wraith JE; Zeman J; Michalski JC; Saftig P; Fogh J; Malm D
    Orphanet J Rare Dis; 2013 Jun; 8():88. PubMed ID: 23786919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive cardiopulmonary assessment in α mannosidosis.
    Nir V; Bentur L; Tal G; Gur M; Gut G; Ilivitzki A; Zucker-Toledano M; Hanna M; Toukan Y; Bar-Yoseph R
    Pediatr Pulmonol; 2020 Sep; 55(9):2348-2353. PubMed ID: 32445542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase.
    Harmatz P; Ketteridge D; Giugliani R; Guffon N; Teles EL; Miranda MC; Yu ZF; Swiedler SJ; Hopwood JJ;
    Pediatrics; 2005 Jun; 115(6):e681-9. PubMed ID: 15930196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and efficacy of velmanase alfa treatment in children under 6 years of age with alpha-mannosidosis: A phase 2, open label, multicenter study.
    Guffon N; Konstantopoulou V; Hennermann JB; Muschol N; Bruno I; Tummolo A; Ceravolo F; Zardi G; Ballabeni A; Lund A
    J Inherit Metab Dis; 2023 Jul; 46(4):705-719. PubMed ID: 36849760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis.
    Lund AM; Borgwardt L; Cattaneo F; Ardigò D; Geraci S; Gil-Campos M; De Meirleir L; Laroche C; Dolhem P; Cole D; Tylki-Szymanska A; Lopez-Rodriguez M; Guillén-Navarro E; Dali CI; Héron B; Fogh J; Muschol N; Phillips D; Van den Hout JMH; Jones SA; Amraoui Y; Harmatz P; Guffon N
    J Inherit Metab Dis; 2018 Nov; 41(6):1225-1233. PubMed ID: 29725868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural course and complications of alpha-mannosidosis--a retrospective and descriptive study.
    Malm D; Riise Stensland HM; Edvardsen Ø; Nilssen Ø
    J Inherit Metab Dis; 2014 Jan; 37(1):79-82. PubMed ID: 23739775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural characterisation of the alpha-mannosidosis guinea pig.
    Robinson AJ; Crawley AC; Auclair D; Weston PF; Hirte C; Hemsley KM; Hopwood JJ
    Behav Brain Res; 2008 Jan; 186(2):176-84. PubMed ID: 17889945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-orphan lysosomal storage diseases: A cross-sectional quantitative analysis of the natural history of alpha-mannosidosis.
    Zielonka M; Garbade SF; Kölker S; Hoffmann GF; Ries M
    J Inherit Metab Dis; 2019 Sep; 42(5):975-983. PubMed ID: 31222755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical evaluation of patients with alpha-mannosidosis - A multicenter study.
    Köse E; Kasapkara ÇS; İnci A; Yıldız Y; Sürücü Kara İ; Kahraman AB; Tümer L; Dursun A; Eminoğlu FT
    Eur J Med Genet; 2024 Apr; 68():104927. PubMed ID: 38382588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of alpha-mannosidosis in paediatric and adult patients: Presentation of a diagnostic algorithm from an international working group.
    Guffon N; Tylki-Szymanska A; Borgwardt L; Lund AM; Gil-Campos M; Parini R; Hennermann JB
    Mol Genet Metab; 2019 Apr; 126(4):470-474. PubMed ID: 30792122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SPARKLE registry: protocol for an international prospective cohort study in patients with alpha-mannosidosis.
    Hennermann JB; Guffon N; Cattaneo F; Ceravolo F; Borgwardt L; Lund AM; Gil-Campos M; Tylki-Szymanska A; Muschol NM
    Orphanet J Rare Dis; 2020 Sep; 15(1):271. PubMed ID: 32993743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme replacement therapy for alpha-mannosidosis: 12 months follow-up of a single centre, randomised, multiple dose study.
    Borgwardt L; Dali CI; Fogh J; Månsson JE; Olsen KJ; Beck HC; Nielsen KG; Nielsen LH; Olsen SO; Riise Stensland HM; Nilssen O; Wibrand F; Thuesen AM; Pearl T; Haugsted U; Saftig P; Blanz J; Jones SA; Tylki-Szymanska A; Guffon-Fouiloux N; Beck M; Lund AM
    J Inherit Metab Dis; 2013 Nov; 36(6):1015-24. PubMed ID: 23494656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality in patients with alpha-mannosidosis: a review of patients' data and the literature.
    Hennermann JB; Raebel EM; Donà F; Jacquemont ML; Cefalo G; Ballabeni A; Malm D
    Orphanet J Rare Dis; 2022 Jul; 17(1):287. PubMed ID: 35871018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-mannosidosis.
    Malm D; Nilssen Ø
    Orphanet J Rare Dis; 2008 Jul; 3():21. PubMed ID: 18651971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosis.
    Harmatz P; Cattaneo F; Ardigò D; Geraci S; Hennermann JB; Guffon N; Lund A; Hendriksz CJ; Borgwardt L
    Mol Genet Metab; 2018 Jun; 124(2):152-160. PubMed ID: 29716835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal analysis of endurance and respiratory function from a natural history study of Morquio A syndrome.
    Harmatz PR; Mengel KE; Giugliani R; Valayannopoulos V; Lin SP; Parini R; Guffon N; Burton BK; Hendriksz CJ; Mitchell JJ; Martins AM; Jones SA; Guelbert N; Vellodi A; Wijburg FA; Yang K; Slasor P; Decker C
    Mol Genet Metab; 2015 Feb; 114(2):186-94. PubMed ID: 25582974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hearing impairment as an early sign of alpha-mannosidosis in children with a mild phenotype: Report of seven new cases.
    Lehalle D; Colombo R; O'Grady M; Héron B; Houcinat N; Kuentz P; Moutton S; Sorlin A; Thevenon J; Delanne J; Gay S; Racine C; Garde A; Tran Mau-Them F; Philippe C; Vitobello A; Nambot S; Huet F; Duffourd Y; Feillet F; Thauvin-Robinet C; Marlin S; Faivre L
    Am J Med Genet A; 2019 Sep; 179(9):1756-1763. PubMed ID: 31241255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-mannosidosis: a report of 2 siblings and review of the literature.
    Govender R; Mubaiwa L
    J Child Neurol; 2014 Jan; 29(1):131-4. PubMed ID: 23307885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme replacement therapy in alpha-mannosidosis guinea-pigs.
    Crawley AC; King B; Berg T; Meikle PJ; Hopwood JJ
    Mol Genet Metab; 2006; 89(1-2):48-57. PubMed ID: 16807033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biochemical analysis of two families with type I and type II mannosidosis.
    Bennet JK; Dembure PP; Elsas LJ
    Am J Med Genet; 1995 Jan; 55(1):21-6. PubMed ID: 7702090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.